14 results
8-K
EX-10.4
MYMD
MyMD Pharmaceuticals Inc
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
not constitute substantive matters to be considered in construing the terms and provisions of this Agreement.
26. Gender and Number. Words of any gender … used in this Agreement shall be held and construed to include any other gender, and words in the singular number shall be held to include the plural
8-K
EX-10.6
MYMD
MyMD Pharmaceuticals Inc
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
and do not constitute substantive matters to be considered in construing the terms and provisions of this Agreement.
23. Gender and Number. Words of any … gender used in this Agreement shall be held and construed to include any other gender, and words in the singular number shall be held to include
8-K
EX-10.5
MYMD
MyMD Pharmaceuticals Inc
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
and convenience purposes only and do not constitute substantive matters to be considered in construing the terms and provisions of this Agreement.
26. Gender … and Number. Words of any gender used in this Agreement shall be held and construed to include any other gender, and words in the singular number shall
S-4/A
EX-10.48
o1ivb8nj
19 Mar 21
Registration of securities issued in business combination transactions (amended)
2:01pm
8-K
EX-2.1
o4oll8s92 mp2sg
12 Nov 20
Akers Biosciences and MyMD Pharmaceuticals Sign Definitive Merger Agreement
5:26pm
8-K
EX-10.1
1l5 cp59lrma
10 Aug 20
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
73lj0
7 Dec 18
Entry into a Material Definitive Agreement
5:15pm
- Prev
- 1
- Next